| Company/Division name | Pine Pharmaceuticals LLC |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 40 |
| Year reshoring announced: | 2021 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | $8.6 |
| City reshored to: | Tonawanda |
| State(s) reshored to: | NY |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | pharmaceuticals |
| What non-domestic negative factors made offshoring less attractive? | Supply chain interruption risk/Natural disaster risk/Political instability |
| What domestic positive factors made reshoring more attractive? | Government Incentives, Impact on domestic economy, covid-19 |
| Government Incentive dollar amount: | $650,000 |
